March 28, 2012 3:53 pm by Brandon Glenn | 0 Comments
The Cleveland Clinic‘s Dr. Steven Nissen, the top cardiologist at the top-rated cardiology hospital in the U.S., recently weighed in on the controversy over medical device failures.“I think people make ...
Read more
January 20, 2012 11:03 am by Brandon Glenn | 0 Comments
Intense grief, such as what’s felt at the death of a spouse, can increase a person’s risk of developing cardiac problems that lead to death, according to a new article ...
Read more
December 28, 2011 5:05 pm by Brandon Glenn | 0 Comments
Two of the Cleveland Clinic‘s greatest doctors ever, Eric Topol and Steven Nissen, have carved out contrasting views on one of the hottest topics in healthcare: personalized medicine.The preeminent cardiologists’ ...
Read more
October 6, 2011 12:44 pm by Brandon Glenn | 2 Comments
Cleveland Clinic’s 2012 Medical Innovation Summit, this year dedicated to cardiovascular technology, has come and gone.But it’s worth taking a look back at a few observations and insights gleaned from ...
Read more
October 5, 2011 7:36 am by Brandon Glenn | 2 Comments
Dr. Steven Nissen, chair of Cleveland Clinic’s cardiovascular medicine department, talks about why head-to-head clinical trials of competing drugs and devices would benefit patients.“In medicine, we have many alternative therapies ...
Read more
January 7, 2011 11:00 am by Chris Seper | 1 Comments
On Thursday, MedCity News' Brandon Glenn floated the idea of Cleveland Clinic's Steven Nissen replacing US Food & Drug Administration Deputy Commissioner Joshua Sharfstein, who left to head Maryland’s ...
Read more
January 6, 2011 12:08 pm by Brandon Glenn | 0 Comments
FDA Deputy Commissioner Joshua Sharfstein's departure may be an olive branch to newly empowered Congressional Republicans. Replacing him with Cleveland Clinic's Steven Nissen would signal the exact opposite from President ...
Read more
October 22, 2010 7:07 pm by Mary Vanac | 0 Comments
Ann Arbor, Michigan, biopharmaceutical company Cerenis Therapeutics added $13.9 million to a July investment round that it will use to continue clinical trials of a drug to treat heart disease. ...
Read more
September 24, 2010 8:56 am by Mary Vanac | 0 Comments
What does Cleveland Clinic cardiologist (and Avandia whistleblower) Steven Nissen have to say about Thursday's Food and Drug Administration decision to allow diabetes drug Avandia to stay on the market ...
Read more
September 23, 2010 8:43 am by Mary Vanac | 0 Comments
Swiss drugmaker Novartis just got Food and Drug Administration approval to sell the first pill that can slow the progression of multiple sclerosis. Gilenya will go head-to-head with injectable medicines, ...
Read more
September 6, 2010 1:37 pm by Mary Vanac | 0 Comments
The British Medical Journal today raised more questions about whether diabetes drug Avandia should ever have been approved for patients in the United States and Europe, and whether the ...
Read more
Dr. Steven Nissen, the Cleveland Clinic’s high-profile cardiovascular medicine chair, is staking his reputation as a drug-safety advocate on a shortened regulatory pathway for a cholesterol-fighting drug made by a ...
Read more
February 22, 2010 7:57 pm by Mary Vanac | 0 Comments
Two years after emerging as an independent with aspirations to become one of the nation's top hospitals, Christ Hospital in Mount Auburn hopes to spend hundreds of millions of dollars ...
Read more
CNN's State of the Union host and chief national correspondent John King went inside the Cleveland Clinic for online and broadcast reports on the next generation of health care in ...
Read more
Nissen is a bit fire-and-brimstone when speaking to the public about the U.S. Food and Drug Administration. But Thursday afternoon, he was standing in front of fellow cardiologists -- as ...
Read more
